Salvia plebeia extract inhibits the inflammatory response in human rheumatoid synovial fibroblasts and a murine model of arthritis

Phytomedicine

Volumn 22, Issue 3, 2015, Pages 415-422

  Choi, Jin Kyeong ^a   Oh, Hyun Mee ^b   Park, Jee Hun ^c   Choi, Jung Ho ^c   Sa, Keum Hee ^a   Kang, Young Mo ^a   Park, Pil Hoon ^d   Shin, Tae Yong ^e   Rho, Mun Chual ^b   Kim, Sang Hyun ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c RandD Center Pharmaceutical lab Korean Drug Co LTD   (South Korea)

^d Yeungnam University   (South Korea)

^e Woosuk University   (South Korea)

Author keywords

Collagen induced arthritis; Salvia plebeia; Synovial fibroblasts

Indexed keywords

ANTIINFLAMMATORY AGENT; CAFFEIC ACID; COLLAGEN TYPE 2; CYTOKINE; HISPIDULIN; HOMOPLANTAGININ; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERSTITIAL COLLAGENASE; KETOPROFEN; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; ROSMARINIC ACID; SALVIA PLEBEIA EXTRACT; STROMELYSIN; UNCLASSIFIED DRUG; HERBACEOUS AGENT; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE; SALVIA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG MECHANISM; FIBROBLAST; FOOT PAD; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INGUINAL LYMPH NODE; JOINT; MALE; MEDIATOR; MEDICINAL PLANT; MOUSE; NONHUMAN; PHENOTYPE; PHYTOCHEMISTRY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RHEUMATOID ARTHRITIS; SALVIA; SALVIA PLEBEIA; SERUM; SYNOVIAL FIBROBLAST; SYNOVIUM; TH1 CELL; TH17 CELL; TH2 CELL; THICKNESS; ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BAGG ALBINO MOUSE; BLOOD; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; PLANT;

MURINAE; SALVIA PLEBEIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DRUGS, CHINESE HERBAL; FIBROBLASTS; HUMANS; IMMUNOGLOBULIN G; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; PLANT COMPONENTS, AERIAL; SALVIA;

EID: 84924286524     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2015.01.007     Document Type: Article

References (32)

1. Ahmed S., Riegsecker S., Beamer M., Rahman A., Bellini J.V., Bhansali P., Tillekeratne L.M. Largazole, a class I histone deacetylase inhibitor, enhances TNF-alpha-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts Toxicol. Appl. Pharmacol. 270 2013 87 96
2. Bottini N., Firestein G.S. Duality of fibroblast-like synoviocytes in RA: Passive responders and imprinted aggressors Nat. Rev. Rheumatol. 9 2013 24 33
3. Burrage P.S., Mix K.S., Brinckerhoff C.E. Matrix metalloproteinases: Role in arthritis Front. Biosci. 11 2006 529 543
4. Cho Y.G., Cho M.L., Min S.Y., Kim H.Y. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis Autoimmun. Rev. 7 2007 65 70
5. Choi J.K., Oh H.M., Lee S., Park J.W., Khang D., Lee S.W., Lee W.S., Rho M.C., Kim S.H. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model Toxicol. Appl. Pharmacol. 269 2013 72 80
6. Coaccioli S. Ketoprofen 2.5% gel: A clinical overview Eur. Rev. Med. Pharmacol. Sci. 15 2011 943 949
7. Dayer J.M., Choy E. Therapeutic targets in rheumatoid arthritis: The interleukin-6 receptor Rheumatology (Oxford) 49 2010 15 24
8. Gu L.W., Weng X.C. Antioxidant activity and components of Salvia plebeia R.Br.-A Chinese herb Food Chem. 73 2001 299 305
9. Hwang J.K., Noh E.M., Moon S.J., Kim J.M., Kwon K.B., Park B.H., You Y.O., Hwang B.M., Kim H.J., Kim B.S., Lee S.J., Kim J.S., Lee Y.R. Emodin suppresses inflammatory responses and joint destruction in collagen-induced arthritic mice Rheumatology (Oxford) 52 2013 1583 1591
10. Jin X.F., Lu Y.H., Wei D.Z., Wang Z.T. Chemical fingerprint and quantitative analysis of Salvia plebeia R.Br. by high-performance liquid chromatography J. Pharm. Biomed. Anal. 48 2008 100 104
11. Juarranz Y., Abad C., Martinez C., Arranz A., Gutierrez-Canas I., Rosignoli F., Gomariz R.P., Leceta J. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis Arthritis. Res. Ther. 7 2005 R1034 R1045
12. Kay J., Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis Rheumatology (Oxford) 43 Suppl 3 2004 iii2 iii9
13. Komatsu T., Sakurada T. Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe Eur. J. Pharm. Sci. 47 2012 890 895
14. Kumar P., Banik S. Pharmacotherapy options in rheumatoid arthritis Clin. Med. Insights. Arthritis. Musculoskelet. Disord. 6 2013 35 43
15. Kumar S., Blake S.M., Emery J.G. Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis Curr. Opin. Pharmacol. 1 2001 307 313
16. Lin G., Li J. Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis Rheumatol. Int. 30 2010 837 840
17. Lu Y., Foo L.Y. Polyphenolics of Salvia - A review Phytochemistry 59 2002 117 140
18. McInnes I.B., Schett G. Cytokines in the pathogenesis of rheumatoid arthritis Nat. Rev. Immunol. 7 2007 429 442
19. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis N. Engl. J. Med. 365 2011 2205 2219
20. Muller-Ladner U., Pap T., Gay R.E., Neidhart M., Gay S. Mechanisms of disease: The molecular and cellular basis of joint destruction in rheumatoid arthritis Nat. Clin. Pract. Rheumatol. 1 2005 102 110
21. Nam E.J., Kang J.H., Sung S., Sa K.H., Kim K.H., Seo J.S., Kim J.H., Han S.W., Kim I.S., Kang Y.M. A MMP1-cleavable composite peptide derived from betaig-h3 potently inhibits chronic inflammatory arthritis Arthritis. Rheum. 65 2013 1753 1763
22. Nugroho A., Kim M.H., Choi J., Baek N.I., Park H.J. In vivo sedative and gastroprotective activities of Salvia plebeia extract and its composition of polyphenols Arch. Pharm. Res. 35 2012 1403 1411
23. Qu X.J., Xia X., Wang Y.S., Song M.J., Liu L.L., Xie Y.Y., Cheng Y.N., Liu X.J., Qiu L.L., Xiang L., Gao J.J., Zhang X.F., Cui S.X. Protective effects of Salvia plebeia compound homoplantaginin on hepatocyte injury Food Chem. Toxicol. 47 2009 1710 1715
24. Shin T.Y., Kim H.M. Inhibition of immediate-type allergic reactions by the aqueous extract of Salvia plebeia Immunopharmacol. Immunotoxicol. 24 2002 303 314
25. Simmonds R.E., Foxwell B.M. Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation Rheumatology (Oxford) 47 2008 584 590
26. Smolen J.S., Aletaha D., Koeller M., Weisman M.H., Emery P. New therapies for treatment of rheumatoid arthritis Lancet 370 2007 1861 1874
27. Tian J., Chen J.W., Gao J.S., Li L., Xie X. Resveratrol inhibits TNF-alpha-induced IL-1beta, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway Rheumatol. Int. 33 2013 1829 1835
28. van den Berg W.B., Miossec P. IL-17 as a future therapeutic target for rheumatoid arthritis Nat. Rev. Rheumatol. 5 2009 549 553
29. van Roon J.A., Glaudemans C.A., Bijlsma J.W., Lafeber F.P. Differentiation of naive CD4+ T cells towards T helper 2 cells is not impaired in rheumatoid arthritis patients Arthritis. Res. Ther. 5 2003 R269 R276
30. Wisler B.A., Dennis J.E., Malemud C.J. New organ-specific pharmacological strategies interfering with signaling pathways in inflammatory disorders/autoimmune disorders Curr. Signal. Transduct. Ther. 6 2011 279 291
31. Xu H., He Y., Yang X., Liang L., Zhan Z., Ye Y., Lian F., Sun L. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes Rheumatology (Oxford) 46 2007 920 926
32. Yoshioka Y., Kozawa E., Urakawa H., Arai E., Futamura N., Zhuo L., Kimata K., Ishiguro N., Nishida Y. Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts Arthritis. Rheum. 65 2013 1160 1170